GT Biopharma

+$0.01 (+0.38%) Today
-$0.01 (-0.37%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.

About GTBP

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells).

CEO
Michael Breen
Employees
8
Headquarters
Brisbane, California
Founded
1965

GTBP Key Statistics

Market cap
88.34M
Price-Earnings ratio
—
Dividend yield
—
Average volume
207.97K
High today
$2.70
Low today
$2.51
Open price
$2.70
Volume
140.45K
52 Week high
$19.73
52 Week low
$1.51

GTBP Earnings

-$3.40
-$2.27
-$1.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.31 per share
Actual
-$0.17 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure